The epidemic of chronic kidney disease: Looking at ageing and cardiovascular disease through kidney-shaped lenses

Journal of Internal Medicine

Volumn 268, Issue 5, 2010, Pages 449-455

  Mangione, F ^a,b   Canton, A Dal ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Ageing; Atherosclerosis; Cardiovascular disease; Chronic kidney disease

Indexed keywords

CREATININE;

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE COURSE; EPIDEMIC; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY STRUCTURE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

AGE FACTORS; AGED; AGING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CREATININE; DIABETES COMPLICATIONS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; PREVALENCE; SEX FACTORS;

EID: 77958547973     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02289.x     Document Type: Article

References (29)

1. Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 2010; 268: 456-67.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-246.
3. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009; 75: 1009-14.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-70.
5. U.S. Renal Data System, USRDS. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
6. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-48.
7. United States Census Bureau. Available at: [accessed on July 2009].
8. European Commission Eurostat database. Available at: [accessed on July 2009].
9. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496-506.
10. Esposito C, Plati AR, Mazzullo T et al. Renal function and functional reserve in healthy elderly individuals. J Nephrol 2007; 20: 617-25.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
12. Verhave JC, Fesler P, Ribstein J, Du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-41.
13. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
14. Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009; 75: 1071-8.
15. Poggio ED, Rule AD, Tanchanco R et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 2009; 75: 1079-87.
16. Delanaye P, Cavalier E, Saint-Remy A, Lutteri L, Krzesisnski JM. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scand J Clin Lab Invest 2009; 69: 344-9.
17. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
18. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10 year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-82.
19. Klahr S, Levey AS, Beck GJ et al. The effects of dietary protein restriction and blood-pressure control on the progression of renal disease. Modification of Diet in Renal Disease Study Group. N Eng J Med 1994; 330: 877-84.
20. Hemmelgarn BR, Zhan J, Manns BJ et al. Progression of kidney dysfunction in the community dwelling elderly. Kidney Int 2006; 69: 2155-61.
21. Go AS, Chertow GM, Fan D, McCulloch CE, Hsuy CY. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Eng J Med 2004; 351: 1296-305.
22. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-41.
23. Kung HC, Hoyert DL, Xu JQ, Murphy SL. Deaths: Final Data for 2005. National Vital Statistics Reports, vol 56 no 10. Hyattsville, MD: National Center for Health Statistics, 2008.
24. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 5: S112-9.
25. O'Hare AM, Berthental D, Covinsky KE et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006; 17: 846-53.
26. Roderick PJ, Atkins RJ, Smeeth L et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009; 53: 950-60.
27. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-25.
28. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
29. Whelton PK, He J, Appel LJ et al. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288:1882-8.